Use of Bovine Serum

EMEA and CPMP published a Note for Guidance on the Use of Bovine Serum in the manufacture of Human Biological Medicinal Products. The guidance was adopted by CPMP (Committee for Proprietary Medicinal Products) at the July 2003 meeting. The date for coming into operation is 1 October 2003.